Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Genovac logo — The gene to antibody company™.

Genovac

The gene to antibody company™.

Founded 1999 United States Fargo, United States 27 employees Biotechnology

General Information

Company Name Genovac
Founded Year 1999
Location United States Fargo, United States +1
Employees 27
Industries Biotechnology
Social

Get notified when Genovac moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genovac

Genovac is a biotechnology startup founded in 1999, positioning itself as "The gene to antibody company™." The company serves as a One-Stop-Shop Gene to Antibody Partner with a focus on antibody discovery and production against challenging targets. Genovac's unique combination of genetic immunization, multiple host species, multiple single B cell platforms, and state-of-the-art production facilities enables it to offer comprehensive services in this space. Currently, there is no information available regarding the startup's headquarters, last investment, or the investors involved. Given its expertise and focus on transformative drugs and diagnostics, Genovac presents itself as a compelling player in the biotechnology sector, with significant potential for growth and impact.

Taxonomy: antibody discovery, genetic immunization, protein production, cDNA synthesis, biopharmaceuticals, diagnostics, contract research, immunization technologies, single B cell screening, antibody production, plasmid production, large-scale production, biologics, pharmaceutical research

No funding data available for Genovac yet.

Get notified when Genovac raises funding

Genovac Alternatives & Competitors

Genovac vs
GenScript ProBio
GenScript ProBio

A comprehensive R&D and production platform offering complete solutions for cell and gene therapy, v...

Series C
1001-5000 employees
Biopharma, Pharmaceutical
Genovac vs
Biointron
Biointron China

Recombinant Antibody Expression, Delivery in 2 weeks (From Gene Sequence to Purified Antibody)

Series B
41 employees
Biotechnology, Health Care
Genovac vs
Pepmic Co., Ltd
Pepmic Co., Ltd China

Committed to Lifescience

10 employees
Biotechnology, Life Sciences

FAQ About Genovac

The gene to antibody company™.
Genovac was founded in 1999.
Genovac is headquartered in Fargo, United States.
Genovac operates in the following industries: Biotechnology.
Genovac has approximately 27 employees.
Top alternatives and competitors to Genovac include GenScript ProBio, Biointron, Pepmic Co., Ltd, GeneFrontier Corp., Synbio Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genovac and GenScript ProBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genovac and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy